Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Current Deferred Revenue (2018 - 2020)

Medifast (MED) has disclosed Current Deferred Revenue for 3 consecutive years, with $7.6 million as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Current Deferred Revenue rose 75.54% year-over-year to $7.6 million, compared with a TTM value of $7.6 million through Dec 2020, up 75.54%, and an annual FY2020 reading of $7.6 million, up 75.54% over the prior year.
  • Current Deferred Revenue was $7.6 million for Q4 2020 at Medifast, up from $4.3 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $7.6 million in Q4 2020 and bottomed at $2.8 million in Q4 2018.
  • Average Current Deferred Revenue over 3 years is $4.9 million, with a median of $4.3 million recorded in 2019.
  • The sharpest move saw Current Deferred Revenue soared 54.92% in 2019, then soared 75.54% in 2020.
  • Year by year, Current Deferred Revenue stood at $2.8 million in 2018, then skyrocketed by 54.92% to $4.3 million in 2019, then skyrocketed by 75.54% to $7.6 million in 2020.
  • Business Quant data shows Current Deferred Revenue for MED at $7.6 million in Q4 2020, $4.3 million in Q4 2019, and $2.8 million in Q4 2018.